Compare BFC & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BFC | OGN |
|---|---|---|
| Founded | 1894 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2018 | 2020 |
| Metric | BFC | OGN |
|---|---|---|
| Price | $139.91 | $13.40 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 5 |
| Target Price | ★ $157.00 | $11.40 |
| AVG Volume (30 Days) | 78.1K | ★ 3.8M |
| Earning Date | 04-16-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.52% | 0.60% |
| EPS Growth | ★ 11.23 | N/A |
| EPS | ★ 1.78 | 0.55 |
| Revenue | N/A | ★ $6,216,000,000.00 |
| Revenue This Year | $58.67 | $0.45 |
| Revenue Next Year | $2.01 | $1.67 |
| P/E Ratio | $76.66 | ★ $24.36 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $109.11 | $5.69 |
| 52 Week High | $153.00 | $13.48 |
| Indicator | BFC | OGN |
|---|---|---|
| Relative Strength Index (RSI) | 46.14 | 74.44 |
| Support Level | $119.60 | $10.05 |
| Resistance Level | $140.93 | $13.46 |
| Average True Range (ATR) | 3.78 | 0.05 |
| MACD | -0.59 | -0.20 |
| Stochastic Oscillator | 44.14 | 39.29 |
Bank First Corp is a United States-based company engaged in providing financial services, a full range of consumer and commercial financial institution services to individuals and businesses, including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.